NeuronX

NeuronX

ICO Ended
11,366 Views
NeuronX at the time of the start of ITO is an information and analytical platform that provides reliable information and trading recommendations on cryptocurrency pairs for the most popular cryptocurrency exchanges.

In the future, we are not just a service with analytics, we are an ecosystem for combining completely different analytical algorithms with potential clients (traders). The ecosystem will be fully decentralized and regulated by the community.

At the moment, we make forecasts for BTC/USDT every minute, which can be seen in the personal account. To improve the accuracy of forecasts, we daily saturate AI with fresh data, experience accumulates, and with it increases the accuracy of predictions.
6.5
TOTAL SCORE
6.9
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 01 Nov 2018 - 03 Feb 2019
ICO Time: 10 Feb 2019 - 30 Apr 2019
Whitelist/KYC: KYC
Country: Estonia
Token info
Ticker: NXBT
Platform: Ethereum
Token Type: ERC20
Financial
Accepting: BTC, ETH, EOS
Hard cap: 20000000. USD
Q1 2018
The development of the concept and architecture of the platform<br />
Q3 2018
Alpha - version of the analytical platform, closed testing and finalization<br /> <br /> Private sale
Q3 2018
Launch a promo-version of the analytical platform<br />
Q4 2018
Implementation of 10 cryptocurrency pairs of the Binance exchange<br /> <br /> Public pre-sale
Q4 2018
Introduction of new Al for candle prediction<br />
Q4 2018
Introduction of Al to filter false signals<br />
Q1 2019
Integration with exchanges: Bitfinex, Bitstamp, Bittrex, Poloniex, Coinbase, HitBTC, and Kraken<br /> <br /> Token sale Stage 1
Q1 2019
Creating a public API for third-party Al developers
Q1 2019
Public launch
Q2 2019
Launch of DSOF
Q2 2019
Launch on exchanges for the currency pairs: DSOF/USDT, DSOF/NXBT<br />
Q3 2019
Conducting public competitions among enthusiasts for the best AI<br />
Q4 2019
Implementation of new algorithms<br />
Screenshots taken on 4 Nov 2018
Grigoriy Balyan
Chief Executive Officer (CEO), Co-founder
Participates in a number of projects
Evgeniy Ryumin
Chief Technical Officer (CTO)
Participates in a number of projects
Grigoriy Muluzyan
Chief Financial Officer (CFO), Co-founder
Participates in a number of projects
Alexander Aleshin
Chief Operating Officer (COO)
Participates in a number of projects
Andrey Norov
Co-Founder
Participates in a number of projects
Jaroslav Ferubko
Co-Founder
Participates in a number of projects
Timur Matveev
Marketing director (CMO)
Participates in a number of projects
Evgeniy Korolev
IR & Pitch Manager
Participates in a number of projects
Andrey Sushenkov
Full stack developer
Participates in a number of projects
Alexander Gorokhov
Back-end developer
Participates in a number of projects
Alexey Zapolskiy
Full stack developer
Participates in a number of projects
Ivan Pastushok
Data Scientist
Participates in a number of projects
Ivan Kalashnik
Front-end developer
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Elements Estates
"Elements Estates is creating a Blockchain-based platform with underlying unique portfolio of real estate deriving from banks’ distressed assets. The platform will offer the ability to utilize ELES tokens through purchase or rent of real estate and other services, all primarily related to newly developed and modern properties in platform ownership. Elements Estates is giving you the opportunity to get involved in something that will enable growth of token value from unlocking the hidden value of the distressed assets deriving from non-performing bank portfolios, usually reserved for major players."
Upcoming
MeFy
Mefy works on a subscription-based model, where the user of MeMe Care subscribes for yearly subscription allowing them any number of tests throughout the year for the cost of just consumables. Through its eConsult feature it connects worldwide doctors to worldwide patients thereby resolving accessibility issues and with its MeMe Edge device, it provides authenticity to the test conducted.
Upcoming
Universal Reward Protocol
By accepting to share their shopping data with the network, a shopper earns reward tokens, while the data is used by retailers to build redemption offers that best suit each customer’s needs. Shoppers can redeem their tokens through these exclusive and personalized offers.
Active
Dether
Dether provides a decentralized peer-to-peer ether network that enables anyone on Earth to buy ether with cash and spend it at physical stores nearby. No bank account is needed, just a mobile phone with internet access. Our belief is that the beauty and power of the Ethereum technology should be easily accessible to all. We’ve decided to put all of our energy and that of the Ethereum community into helping us build the first trustless solution that will allow anyone to be able to interact with the Ethereum blockchain no matter who you are, where you are, and without the need for a middleman.
Upcoming
Universal Recognition Token
Universal Recognition Token is the first blockchain-based corporate rewards marketplace where employees may sell and auction their gifts, rewards and prizes to the general public. URT is disrupting a $90 billion dollar annual spend market in the United States alone, according to the Incentive Federation.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.